QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.
äŒæ¥ã³ãŒãQDEL
äŒç€ŸåQuidelOrtho Corp
äžå Žæ¥Feb 01, 1991
æé«çµå¶è²¬ä»»è
ãCEOãBlaser (Brian J)
åŸæ¥å¡æ°6600
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Feb 01
æ¬ç€Ÿæåšå°9975 Summers Ridge Road
éœåžSAN DIEGO
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·92121
é»è©±çªå·18585521100
ãŠã§ããµã€ãhttps://www.quidelortho.com/
äŒæ¥ã³ãŒãQDEL
äžå Žæ¥Feb 01, 1991
æé«çµå¶è²¬ä»»è
ãCEOãBlaser (Brian J)
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã

ããŒã¿ãªã